Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Teresa Cibeira López
Observed names:
Cibeira López, Maria Teresa,
M. Lopez,
Maria Teresa Cibeira Lopez,
María Teresa Cibeira López
Observed institutions:
Hospital Clínic de Barcelona,
Universitat de Barcelona
OpenAlex ID:
A5114104683
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
2026
·
Efstathios Kastritis
, Giovanni Palladini
, et al.
·
Blood
·
4
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
2026
·
Ashutosh D. Wechalekar
, Angela Dispenzieri
, et al.
·
Journal of Clinical Oncology
·
2
Outcomes of patients with light-chain amyloidosis after heart transplantation: A single center cohort.
2025
·
Jose Miguel Mateos Perez
, Carlos Fernandez de Larrea
, et al.
·
Blood
PDF
Operational cure in patients with newly diagnosed multiple myeloma after autologous stem cell transplantation: Long-term survivors and impact of induction regimens.
2025
·
Jose Miguel Mateos Perez
, Francesc Fernández-Avilés
, et al.
·
Blood
PDF
Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study
2023
·
Eli Muchtar
, Giovanni Palladini
, et al.
·
Blood
Pf588 Significant Pom Effect on the Immune‐cell Profiles in B, T and Nk Subsets in a Large Cohort Clinical Trial in Relapsed/refractory Myeloma
2019
·
R. Prabhala
, M. Samur
, et al.
·
HemaSphere
Natural history and prognostic impact of oligoclonal humoral response in patients term results from a single institution
2013
·
Tovar Gomis, Natalia
, Fernández de Larrea Rodríguez, Carlos José
, et al.
·
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Mieloma múltiple: implicaciones terapéuticas de la angiogénesis
2009
·
María Teresa Cibeira López
·
Dialnet (Universidad de la Rioja)
Show more works
View as search
Works count:
8
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type
